Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Published 22/02/2024, 12:23
Updated 22/02/2024, 13:40
© Reuters.  Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Piper Sandler raised the price target for Wix.com Ltd. (NASDAQ: WIX) from $146 to $165. Piper Sandler analyst Clarke Jeffries maintained an Overweight rating. Wix.com shares rose 5.9% to close at $132.77 on Thursday. See how other analysts view this stock.
  • Keybanc boosted Analog Devices, Inc. (NASDAQ: ADI) price target from $220 to $230. Keybanc analyst John Vinh maintained an Overweight rating. Analog Devices shares gained 2.3% to close at $193.72 on Wednesday. See how other analysts view this stock.
  • Needham raised the price target for Glaukos Corporation (NYSE: GKOS) from $105 to $108. Needham analyst David Saxon maintained a Buy rating. Glaukos shares rose 0.7% to close at $92.79 on Wednesday. See how other analysts view this stock.
  • TD Cowen raised Wingstop Inc. (NASDAQ: WING) price target from $295 to $355. TD Cowen analyst Andrew Charles maintained an Outperform rating. Wingstop shares fell 4.4% to close at $310.32 on Wednesday. See how other analysts view this stock.
  • Chardan Capital increased the price target for CRISPR Therapeutics AG (NASDAQ: CRSP) from $110 to $112. Chardan Capital analyst Geulah Livshits maintained a Buy rating. CRISPR Therapeutics shares gained 4.7% to close at $82.41 on Wednesday. See how other analysts view this stock.
  • Wedbush cut the price target for Jack in the Box Inc. (NASDAQ: JACK) from $83 to $79. Wedbush analyst Nick Setyan maintained a Neutral rating. Jack in the Box shares gained 0.3% to close at $73.95 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. cut Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) price target from $15 to $13. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. Aurinia Pharmaceuticals shares gained 2.7% to close at $5.74 on Wednesday. See how other analysts view this stock.
  • TD Cowen increased Coty Inc. (NYSE: COTY) price target from $13 to $16. TD Cowen analyst Oliver Chen upgraded the stock from Market Perform to Outperform. Coty shares gained 3.9% to close at $12.64 on Wednesday. See how other analysts view this stock.
  • Needham boosted Ultra Clean Holdings, Inc. (NASDAQ: UCTT) price target from $46 to $50. Needham analyst Charles Shi maintained a Buy rating. Ultra Clean shares gained 1% to close at $42.21 on Wednesday. See how other analysts view this stock.
  • Cantor Fitzgerald raised Root, Inc. (NASDAQ: ROOT) price target from $9 to $13. H Cantor Fitzgerald analyst Josh Siegler upgraded the stock from Neutral to Overweight. Root shares fell 4.4% to close at $8.67 on Wednesday. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: NVIDIA, Keurig Dr Pepper And 3 Stocks To Watch Heading Into Thursday

Latest Ratings for ADI

Feb 2022Morgan StanleyMaintainsEqual-Weight
Feb 2022CitigroupMaintainsBuy
Jan 2022BarclaysMaintainsOverweight

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.